| Literature DB >> 31509976 |
Bolat Sultankulov1, Dmitriy Berillo2,3, Karina Sultankulova4, Tursonjan Tokay5, Arman Saparov6.
Abstract
Over the last few decades, chitosan has become a good candidate for tissue engineering applications. Derived from chitin, chitosan is a unique natural polysaccharide with outstanding properties in line with excellent biodegradability, biocompatibility, and antimicrobial activity. Due to the presence of free amine groups in its backbone chain, chitosan could be further chemically modified to possess additional functional properties useful for the development of different biomaterials in regenerative medicine. In the current review, we will highlight the progress made in the development of chitosan-containing bioscaffolds, such as gels, sponges, films, and fibers, and their possible applications in tissue repair and regeneration, as well as the use of chitosan as a component for drug delivery applications.Entities:
Keywords: biomaterials; bone; cartilage; chitosan; regenerative medicine; tissue engineering
Mesh:
Substances:
Year: 2019 PMID: 31509976 PMCID: PMC6770583 DOI: 10.3390/biom9090470
Source DB: PubMed Journal: Biomolecules ISSN: 2218-273X
Figure 1Chitin and chitosan structure.
Figure 2Main properties of chitosan (CS) used for skin, bone, and cartilage regeneration.
Chitosan and its derivatives for drug delivery. NPs: nanoparticles.
| CS/Derivatives | Type/Delivery System | Application | Ref. |
|---|---|---|---|
| Self-assembled polymeric micelles | Controlled anticancer drug release | [ | |
| Tumor targeted therapy | [ | ||
| Biomedical optical imaging | [ | ||
| Self-assembled polymeric micelles | Controlled anticancer drug release | [ | |
| Tumor targeted therapy | [ | ||
| Self-assembled polymeric micelles | Absorption enhancement of anticancer drug | [ | |
| Tumor targeted therapy | [ | ||
| Increasing stability of drug loaded liposomes | [ | ||
| 2-[phenylhydrazine (or hydrazine)-thiosemicarbazone]-chitosan | Powder | Pharmaceutical and food industries | [ |
| (Ser-Ile-Lys-Val-Ala-Val) peptide-modified chitosan | Hydrogel | Skin substitutes for wound closure in mice | [ |
| Galactosylated chitosan (GC) | NPs | Tumor targeted therapy | [ |
| siRNA delivery | [ | ||
| MPs and micelles | Tumor targeted therapy | [ | |
| Liposomes | Intestinal drug delivery | [ | |
| Hydroxyapatite/CS | NPs | Drug delivery | [ |
| CS loaded with antioxidant NPs | Hydrogel | Drug release | [ |
| PEGylated CS | NPs | Tumor targeted therapy | [ |
| Chitosan-based vaccine | Polyelectrolyte, NPs | Intranasal CS-DNA vaccine | [ |